Verve Therapeutics
VERV
#7076
Rank
โ‚น32.89 B
Marketcap
โ‚น388.59
Share price
1.10%
Change (1 day)
-59.24%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น13.12 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are โ‚น13.12 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น12.75 B20.12%
2022-12-31โ‚น10.61 B432.76%
2021-12-31โ‚น1.99 B-80.86%
2020-12-31โ‚น10.40 B254.27%
2019-12-31โ‚น2.93 B